CTLA4 and non-small cell lung carcinoma: In NSCLC, cytotoxic T-lymphocyte antigen-4 (CTLA-4) has been demonstrated to be a robust inducer of Treg function [35], and CD4 and CD8 Tregs may serve as potential prognostic biomarkers [36].